Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)197

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)91

Views

Views
January 202610
February 20261
March 202613
April 202617
May 202639
June 202610
July 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States36
Italy32
Netherlands4
Venezuela3
United Kingdom3
Mexico2
Argentina2
Brazil1
Canada1
Spain1
 

Top cities views

Views
Arezzo32
San Jose10
Groningen3
Ashburn3
Amsterdam1
Atlanta1
Blackwood1
Boulay-Moselle1
Buffalo1
Cuauhtémoc1